Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

about

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

Item

http://www.wikidata.org/entity/Q57111080

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 13 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

@en

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

@nl

type

Item

label

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

@en

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

@nl

prefLabel

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

@en

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

@nl

P1476

Emerging Therapies in the Management of Advanced-Stage Gastric Cancer

@en

P2093

Abhinav B Chandra

http://www.w3.org/2001/XMLSchema#string

Mohit Garg

http://www.w3.org/2001/XMLSchema#string

Parita Soni

http://www.w3.org/2001/XMLSchema#string

Stephan Kamholz

http://www.w3.org/2001/XMLSchema#string

P2860

The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients

Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression

Lymphocyte-activation gene-3, an important immune checkpoint in cancer

Novel targets in the treatment of advanced gastric cancer: a perspective review

Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy

MEK and PI3K inhibition in solid tumors: rationale and evidence to date

Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier

Therapies targeting cancer stem cells: Current trends and future challenges

Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

P304

404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00404

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vivek Kumar

P577

2018-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30271341

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6146175

http://www.w3.org/2001/XMLSchema#string